Transvaginal Mesh Patch : Uses, Risks and Lawsuits

Childbirth can lead to many complications for the mother. Two of the most common conditions that prevail after childbirth are Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). Both of these conditions generate various complications and symptoms for the new mothers. There are many products in the market by various multinational companies like Bard, Johnson & Johnson (J&J) and American Medical Systems. The products which are introduced by the companies intended to solve these conditions. However, it was the one solution that has been considered as the creation of the transvaginal mesh slings or the patches. On the other hand, it has been far and wide published by various scientific, medical and the research journals and now by the US FDA that these products could be many times defective which may lead to many serious and sometimes fatal complications for patients.

When a woman is on a kid, there are usually damages in the genital tissues, tearing and other related complications that are inflicted on the abdominal area in consequence of labor pains and delivery. If the tissue damage is left untreated, it can keep on increasing the pressure on the urinary bladder and also the pressure on the abdominal organs. These are often considered as the signs and symptoms of Pelvic Organ Prolapse (POP) and/or Stress Urinary Incontinence (SUI). Various companies, manufactured transvaginal mesh patches and slings which were surgically implanted into the human female patients to secure from problems with the tissues which do not stay in place. Conversely, a number of patients have alleged that these patches have enrooted them serious pains, perforation of the bowel or bladder and also other significant health problems.

The Transvaginal Mesh was intended to help, support internal organs that were formerly supported by the vaginal wall, but now the vaginal wall have extensively stretched, such as the kind that come about during childbirth or surgery. A surgeon inserts the mesh patch and stretches it across the vaginal wall in an effort to provide additional support to the internal organs.

Several serious injuries have been accounted for the potentially defective Transvaginal Mesh Patches. The Food and Drug Administration (FDA), as well as other intellectual medical journals, have brought to the notice of people about the thousands of incidents of impending fatal complications which associated with the Transvaginal Mesh Patches.

The Increased awareness of the potential side effects of having a Transvaginal Mesh patch inserted by a surgery has caused an incursion of litigation filed against various medical companies. As of May 8th, 2012 more than 1000 lawsuits have been filed in various law bodies under the supervision of transvaginal mesh patch lawyers; these numbers are for sure known to rise as more and most victims are experiencing the harmful side effects and are converted as awareness of the potential impact on their health is moving forward.

While litigation persists to be filed in countries, other litigation has been filed throughout the country up to that time. It has been documented that thousands of lawsuits have been filed, and the above mentioned Multinational companies are named frequently in the complaint.